Skip to content

Study · Not a test of the peptide alone · 2016

12 results

Triptorelin and cetrorelix induce immune responses and affect uterine development and expressions of genes and proteins of ESR1, LHR, and FSHR of mice.

Wei S, Guo H, Gong Z, Zhang F, Ma Z

Immunopharmacology and immunotoxicology14 Apr 2016Cited by 11 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study12

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone12

In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  1. 01AnimalNot a test of Triptorelin (Trelstar, Decapeptyl) aloneAnimal study (in vivo)Efficacy outcome

    In mice, TRI-2 antigen immunization reduced uterine weight compared with controls.

    In plain wordsIn mice, TRI-2 antigen immunization reduced uterine weight compared with controls.

    Outcome
    DecreaseUterine weight with TRI-2
    Study

    micen: not reported in source

    Uterine development after TRI antigen immunization
    Comparator
    Control group
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Measurements

    Uterine weight reduction
    28.57%
    TRI-2

    Source sentences

    Summary
    Uterine weights of TRI-2, TRI-3 reduced by 28.57% and 11.43% (p < 0.05), respectively.
    3 context sentences
    Summary · context
    The study investigated the effects of active immunity of GnRH agonist and antagonist on uterine development, microstructures, expression of hormone receptors mRNAs, and proteins in uteri.
    Summary · context
    One hundred and five mice were assigned into CET, TRI, and control groups (CG).
    Summary · context
    Mice in TRI-1, TRI-2, and TRI-3 were injected with 10, 20, and 40 μg TRI antigens for seven days, respectively.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  2. 02AnimalNot a test of Triptorelin (Trelstar, Decapeptyl) aloneAnimal study (in vivo)Efficacy outcome

    In mice, TRI-3 antigen immunization reduced uterine weight compared with controls.

    In plain wordsIn mice, TRI-3 antigen immunization reduced uterine weight compared with controls.

    Outcome
    DecreaseUterine weight with TRI-3
    Study

    micen: not reported in source

    Uterine development after TRI antigen immunization
    Comparator
    Control group
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Measurements

    Uterine weight reduction
    11.43%
    TRI-3

    Source sentences

    Summary
    Uterine weights of TRI-2, TRI-3 reduced by 28.57% and 11.43% (p < 0.05), respectively.
    3 context sentences
    Summary · context
    The study investigated the effects of active immunity of GnRH agonist and antagonist on uterine development, microstructures, expression of hormone receptors mRNAs, and proteins in uteri.
    Summary · context
    One hundred and five mice were assigned into CET, TRI, and control groups (CG).
    Summary · context
    Mice in TRI-1, TRI-2, and TRI-3 were injected with 10, 20, and 40 μg TRI antigens for seven days, respectively.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  3. 03AnimalNot a test of Triptorelin (Trelstar, Decapeptyl) aloneAnimal study (in vivo)Efficacy outcome

    In mice, the uterine cavity narrowed slightly in the TRI-1 antigen group.

    In plain wordsIn mice, the uterine cavity narrowed slightly in the TRI-1 antigen group.

    Outcome
    DecreaseUterine cavity width
    Study

    micen: not reported in source

    Uterine development after TRI antigen immunization
    Comparator
    Control group
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Source sentences

    Summary
    Uterine cavity became narrow slightly in TRI-1.
    3 context sentences
    Summary · context
    The study investigated the effects of active immunity of GnRH agonist and antagonist on uterine development, microstructures, expression of hormone receptors mRNAs, and proteins in uteri.
    Summary · context
    One hundred and five mice were assigned into CET, TRI, and control groups (CG).
    Summary · context
    Mice in TRI-1, TRI-2, and TRI-3 were injected with 10, 20, and 40 μg TRI antigens for seven days, respectively.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  4. 04AnimalNot a test of Triptorelin (Trelstar, Decapeptyl) aloneAnimal study (in vivo)Efficacy outcome

    In mice, uterine gland counts decreased in the TRI antigen group.

    In plain wordsIn mice, uterine gland counts decreased in the TRI antigen group.

    Outcome
    DecreaseUterine gland count
    Study

    micen: not reported in source

    Uterine development after TRI antigen immunization
    Comparator
    Control group
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Source sentences

    Summary
    Numbers of uterine glands reduced.
    4 context sentences
    Summary · context
    In TRI group, the uterine wall thinned.
    Summary · context
    The study investigated the effects of active immunity of GnRH agonist and antagonist on uterine development, microstructures, expression of hormone receptors mRNAs, and proteins in uteri.
    Summary · context
    One hundred and five mice were assigned into CET, TRI, and control groups (CG).
    Summary · context
    Mice in TRI-1, TRI-2, and TRI-3 were injected with 10, 20, and 40 μg TRI antigens for seven days, respectively.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  5. 05AnimalNot a test of Triptorelin (Trelstar, Decapeptyl) aloneAnimal study (in vivo)Efficacy outcome

    In mice, endometrial epithelial thickness decreased in the TRI-1 antigen group.

    In plain wordsIn mice, endometrial epithelial thickness decreased in the TRI-1 antigen group.

    Outcome
    DecreaseEndometrial epithelial thickness
    Study

    micen: not reported in source

    Uterine development after TRI antigen immunization
    Comparator
    Control group
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Measurements

    Endometrial epithelial thickness decrease
    13.69%
    TRI-1

    Source sentences

    Summary
    EET in TRI-1 was decreased by 13.69%.
    3 context sentences
    Summary · context
    The study investigated the effects of active immunity of GnRH agonist and antagonist on uterine development, microstructures, expression of hormone receptors mRNAs, and proteins in uteri.
    Summary · context
    One hundred and five mice were assigned into CET, TRI, and control groups (CG).
    Summary · context
    Mice in TRI-1, TRI-2, and TRI-3 were injected with 10, 20, and 40 μg TRI antigens for seven days, respectively.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  6. 06AnimalNot a test of Triptorelin (Trelstar, Decapeptyl) aloneAnimal study (in vivo)Efficacy outcome

    In mice, TRI-1 antigen immunization reduced uterine wall thickness compared with controls.

    In plain wordsIn mice, TRI-1 antigen immunization reduced uterine wall thickness compared with controls.

    Outcome
    DecreaseUterine wall thickness with TRI-1
    Study

    micen: not reported in source

    Uterine development after TRI antigen immunization
    Comparator
    Control group
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Measurements

    Uterine wall thickness reduction
    29.35%
    TRI-1

    Source sentences

    Summary
    UWT of TRI-1, TRI-2, and TRI-3 reduced by 29.35, 15.36, and 14.41%, respectively.
    3 context sentences
    Summary · context
    The study investigated the effects of active immunity of GnRH agonist and antagonist on uterine development, microstructures, expression of hormone receptors mRNAs, and proteins in uteri.
    Summary · context
    One hundred and five mice were assigned into CET, TRI, and control groups (CG).
    Summary · context
    Mice in TRI-1, TRI-2, and TRI-3 were injected with 10, 20, and 40 μg TRI antigens for seven days, respectively.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  7. 07AnimalNot a test of Triptorelin (Trelstar, Decapeptyl) aloneAnimal study (in vivo)Efficacy outcome

    In mice, TRI-2 antigen immunization reduced uterine wall thickness compared with controls.

    In plain wordsIn mice, TRI-2 antigen immunization reduced uterine wall thickness compared with controls.

    Outcome
    DecreaseUterine wall thickness with TRI-2
    Study

    micen: not reported in source

    Uterine development after TRI antigen immunization
    Comparator
    Control group
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Measurements

    Uterine wall thickness reduction
    15.36%
    TRI-2

    Source sentences

    Summary
    UWT of TRI-1, TRI-2, and TRI-3 reduced by 29.35, 15.36, and 14.41%, respectively.
    3 context sentences
    Summary · context
    The study investigated the effects of active immunity of GnRH agonist and antagonist on uterine development, microstructures, expression of hormone receptors mRNAs, and proteins in uteri.
    Summary · context
    One hundred and five mice were assigned into CET, TRI, and control groups (CG).
    Summary · context
    Mice in TRI-1, TRI-2, and TRI-3 were injected with 10, 20, and 40 μg TRI antigens for seven days, respectively.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  8. 08AnimalNot a test of Triptorelin (Trelstar, Decapeptyl) aloneAnimal study (in vivo)Efficacy outcome

    In mice, TRI-3 antigen immunization reduced uterine wall thickness compared with controls.

    In plain wordsIn mice, TRI-3 antigen immunization reduced uterine wall thickness compared with controls.

    Outcome
    DecreaseUterine wall thickness with TRI-3
    Study

    micen: not reported in source

    Uterine development after TRI antigen immunization
    Comparator
    Control group
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Measurements

    Uterine wall thickness reduction
    14.41%
    TRI-3

    Source sentences

    Summary
    UWT of TRI-1, TRI-2, and TRI-3 reduced by 29.35, 15.36, and 14.41%, respectively.
    3 context sentences
    Summary · context
    The study investigated the effects of active immunity of GnRH agonist and antagonist on uterine development, microstructures, expression of hormone receptors mRNAs, and proteins in uteri.
    Summary · context
    One hundred and five mice were assigned into CET, TRI, and control groups (CG).
    Summary · context
    Mice in TRI-1, TRI-2, and TRI-3 were injected with 10, 20, and 40 μg TRI antigens for seven days, respectively.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  9. 09AnimalNot a test of Triptorelin (Trelstar, Decapeptyl) aloneAnimal study (in vivo)Mechanism

    In mice, ESR1, FSHR, and LHR mRNA expression increased with TRI antigen immunization.

    In plain wordsIn mice, ESR1, FSHR, and LHR mRNA expression increased with TRI antigen immunization.

    Outcome
    IncreaseReceptor mRNA expression
    Study

    micen: not reported in source

    Uterine development after TRI antigen immunization
    Comparator
    Control group
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Source sentences

    Summary
    Expressions of ESR1, FSHR, and LHR mRNAs in CET and TRI mice increased.
    3 context sentences
    Summary · context
    The study investigated the effects of active immunity of GnRH agonist and antagonist on uterine development, microstructures, expression of hormone receptors mRNAs, and proteins in uteri.
    Summary · context
    One hundred and five mice were assigned into CET, TRI, and control groups (CG).
    Summary · context
    Mice in TRI-1, TRI-2, and TRI-3 were injected with 10, 20, and 40 μg TRI antigens for seven days, respectively.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  10. 10AnimalNot a test of Triptorelin (Trelstar, Decapeptyl) aloneAnimal study (in vivo)Mechanism

    In mice, TRI antigen immunization increased ESR1 protein, with the maximum in TRI-3.

    In plain wordsIn mice, TRI antigen immunization increased ESR1 protein, with the maximum in TRI-3.

    Outcome
    IncreaseESR1 protein
    Study

    micen: not reported in source

    Uterine development after TRI antigen immunization
    Comparator
    Control group
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Source sentences

    Summary
    ESR1 and FSHR protein levels increased in all experimental mice (p < 0.05), with a maximum of TRI-3.
    3 context sentences
    Summary · context
    The study investigated the effects of active immunity of GnRH agonist and antagonist on uterine development, microstructures, expression of hormone receptors mRNAs, and proteins in uteri.
    Summary · context
    One hundred and five mice were assigned into CET, TRI, and control groups (CG).
    Summary · context
    Mice in TRI-1, TRI-2, and TRI-3 were injected with 10, 20, and 40 μg TRI antigens for seven days, respectively.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  11. 11AnimalNot a test of Triptorelin (Trelstar, Decapeptyl) aloneAnimal study (in vivo)Mechanism

    In mice, TRI antigen immunization increased FSHR protein, with the maximum in TRI-3.

    In plain wordsIn mice, TRI antigen immunization increased FSHR protein, with the maximum in TRI-3.

    Outcome
    IncreaseFSHR protein
    Study

    micen: not reported in source

    Uterine development after TRI antigen immunization
    Comparator
    Control group
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Source sentences

    Summary
    ESR1 and FSHR protein levels increased in all experimental mice (p < 0.05), with a maximum of TRI-3.
    3 context sentences
    Summary · context
    The study investigated the effects of active immunity of GnRH agonist and antagonist on uterine development, microstructures, expression of hormone receptors mRNAs, and proteins in uteri.
    Summary · context
    One hundred and five mice were assigned into CET, TRI, and control groups (CG).
    Summary · context
    Mice in TRI-1, TRI-2, and TRI-3 were injected with 10, 20, and 40 μg TRI antigens for seven days, respectively.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  12. 12AnimalNot a test of Triptorelin (Trelstar, Decapeptyl) aloneAnimal study (in vivo)Mechanism

    In mice, TRI antigen immunization increased LHR protein, with the maximum in TRI-3.

    In plain wordsIn mice, TRI antigen immunization increased LHR protein, with the maximum in TRI-3.

    Outcome
    IncreaseLHR protein
    Study

    micen: not reported in source

    Uterine development after TRI antigen immunization
    Comparator
    Control group
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Source sentences

    Summary
    LHR protein levels of TRI group increased, with a maximum of TRI-3 (p < 0.05).
    3 context sentences
    Summary · context
    The study investigated the effects of active immunity of GnRH agonist and antagonist on uterine development, microstructures, expression of hormone receptors mRNAs, and proteins in uteri.
    Summary · context
    One hundred and five mice were assigned into CET, TRI, and control groups (CG).
    Summary · context
    Mice in TRI-1, TRI-2, and TRI-3 were injected with 10, 20, and 40 μg TRI antigens for seven days, respectively.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    27 Oct 2026, 16:35 UTC

    Study data updated · source update from Europe PMC

  2. Version 2

    22 Oct 2026, 02:26 UTC

    Study results updated

  3. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.